English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
71086900 commented on a stock · May 3, 2022 16:23

Matter of Time

Refreshing some news here: $CLARUS THERAPEUTICS HLDGS INC (CRXT.US)$ Institutional investors and hedge funds increased their positions in the 4th quarter. Powell Investment Advisors increased its stake in shares of Clarus Therapeutics by 48.8%. Telemetry Investments purchased additional shares valued at $240,000. UBS acquired shares valued at $206,000. Schonfeld purchased shares valued at about $51,000. Citadel acquired more shares valued at about $31,000. Institutional investors own about 20% of the company’s stock.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
+0
1
Translate
Report
11K Views
Comment
Sign in to post a comment
avatar
0
Followers
0
Following
0
Visitors
Heat List
US
SymbolMini ChartPrice
NVDA
NVIDIA
-- 138.850
TSLA
Tesla
-- 355.840
BABA
Alibaba
-- 124.730
INTC
Intel
-- 23.600
SMCI
Super Micro Computer
-- 47.910
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.